NEW YORK–(BUSINESS WIRE)–Piper Jaffray Companies (NYSE: PJC), a number one funding financial institution and institutional securities agency, will host its 31st annual Healthcare Convention in New York on December Three-5, 2019.
The Piper Jaffray Healthcare Convention will showcase senior administration groups from 374 main private and non-private firms delivering shows to an viewers of greater than 2,500 institutional asset managers, non-public fairness and enterprise capital traders. This yr’s three-day convention will host greater than 2,000 non-public one-on-one conferences with firm administration. Presenting firms signify a number of healthcare sectors, together with: biotechnology, specialty prescription drugs, medical know-how, medical diagnostics, and healthcare IT & providers.
Highlighting the convention might be a number of panel discussions that includes trade specialists, physicians and academicians moderated by Piper Jaffray healthcare senior analysis analysts:
Views on Business-Broad Opioid Litigation
Moderated by David Amsellem
Present Developments & The Way forward for Diabetes Know-how
Moderated by Matt O’Brien
Political/Regulatory Panel: A Dialogue of Key Points Impacting Medtech & The Broader Healthcare House
Moderated by Matt O’Brien
- The Efficacy and Pharmacokinetics of Hashish and Subsequent Gen Cannabinoid Merchandise
- Way forward for Cannabinoid Biosynthesis
Multi-State Operators tackle Medicinal Hashish
Moderated by Michael Lavery
“The Piper Jaffray Healthcare Convention offers traders with distinctive insights into forefront applied sciences benefiting the lives of individuals around the globe and matters impacting our healthcare trade. Our purchasers will obtain a definite and unique expertise to information their investing methods in 2020 and past,” mentioned Michael Cox, co-head of world equities at Piper Jaffray.
Comply with the dialog utilizing the occasion hashtag #PJCHCC19
Firm and investor participation within the convention is by invitation solely. Purchasers fascinated about attending ought to contact their Piper Jaffray consultant. Basic and research-related media inquiries needs to be directed to email@example.com. All different media inquiries needs to be directed to Pamela Steensland at firstname.lastname@example.org.
Data as of December 2, 2019. Topic to alter.
ABOUT PIPER JAFFRAY
Piper Jaffray Companies (NYSE: PJC) is a number one funding financial institution and institutional securities agency pushed to assist purchasers Understand the Energy of Partnership®. Securities brokerage and funding banking providers are provided within the U.S. by Piper Jaffray & Co., member SIPC and FINRA; in Europe by Piper Jaffray Ltd., licensed and controlled by the U.Okay. Monetary Conduct Authority; and in Hong Kong by Piper Jaffray Hong Kong Restricted, licensed and controlled by the Securities and Futures Fee. Asset administration services are provided by 4 separate funding advisory associates. U.S. Securities and Change Fee (SEC) registered Piper Jaffray Funding Administration LLC, PJC Capital Companions LLC and Piper Jaffray & Co., and Guernsey-based Parallel Basic Companions Restricted, licensed and controlled by the Guernsey Monetary Providers Fee.
Since 1895. Member SIPC and NYSE. © 2019 Piper Jaffray Firms, 800 Nicollet Mall, Suite 1000, Minneapolis, Minnesota 55402-7036